Bull&Bear | Editas Medicine Soars 171% Amidst Bullish Momentum

Stock Performers:

Editas Medicine (EDIT) surged 83.91%, marking a five-day consecutive increase, with a total rise of 171.19% over the past five days. Editas Medicine recently received a buy rating from TD Cowen, which contributed to its substantial upward momentum.

Alpha Technology (ATGL) rose by 28.87%, continuously increasing for three days, showing a 64.39% increase over the past three days. As a new star in artificial intelligence, ATGL has sparked a wave of investor enthusiasm. Riding the surge in technology advancement, this stock is perceived by some as having the potential for 100-fold growth.

Golden Matrix Group (GMGI) increased by 31.89%, following a two-day rise, totaling a 32.61% increase over two days. A major stock acquisition by key investors in Golden Matrix Group has been a driving factor in its recent price escalation.

MicroVision (MVIS) rose by 31.58%. Coverage by D. Boral Capital, which provided a buy rating and set a target price of $3, has positively impacted MicroVision's stock performance.

Compass (COMP) climbed by 28.32%, enjoying a six-day streak of gains, with a rise of 38.75% over the past six days. Garmin released better-than-expected performance results, which contributed to the upward synergy among major stocks including SolarEdge Technologies, Compass, Appian, and others on Wednesday.

Stock Decliners:

Bumble (BMBL) dropped by 30.31%, experiencing a two-day consecutive decline, with a total drop of 33.27% over the past two days. Bumble shares plummeted due to weak first-quarter guidance and a decrease in paid users.

PROG Holdings (PRG) fell by 28.37%, with a three-day continuous decrease, dropping 29.75% over the last three days. PROG Holdings witnessed a drop of over 25%, potentially marking the largest percentage decline since June 2022.

Celanese (CE) declined by 21.46%. BMO Capital Markets maintained a sell rating on Celanese and reduced its target price from $73 to $46, exerting downward pressure on the stock price.

Septerna (SEPN) decreased by 19.21%, following a two-day drop, with an overall fall of 57.18% over two days. Septerna shares plunged to new lows after announcing the conclusion of trials.

GCL Global (GCL) fell by 18.00%. After completing a business merger with RF Acquisition Corp, GCL began trading on the NASDAQ with detailed trading information and marked the occasion with a bell-ringing ceremony to commemorate its listing.